Skip to main content
. 2019 Feb 20;11(2):248. doi: 10.3390/cancers11020248

Figure 1.

Figure 1

The synthesis of CD38-S3I-NP. (A) Chemical reactions of the anti-CD38 conjugation to PEO-b-PBCL, the building block of our nanoparticles (NP). The final product was mixed with S3I-NP to generate CD38-S3I-NP. (B) The release of S3I-1757 from S3I-NP or CD38-S3I-NP in vitro. The percentage of S3I-1757 released was calculated by the lost amount of S3I-1757 compared to the initial total amount of S3I-1757. The error bar represents the standard deviation from a triplicate experiment; * p < 0.05, via Student’s t-test.